-
to map pathology-related changes in glycosaminoglycans on breast cancer cells Principal supervisor: Professor Kevin Gough Other supervisors: Professor Cathy Merry, Dr Cinzia Allegrucci, Dr Jennifer
-
are motivated, curious and passionate about scientific research. Together we will make technological advances in cancer research that can make a difference in the way the cancer is diagnosed or even treated
-
aerospace and transport sectors and the imaging of properties of biological cells and tissue. Motivation: Cancer claims the lives of over 450 UK citizens every single day. The best outcomes in patients
-
at the University of Nottingham in collaboration with Erebagen Ltd to screen engineered bacterial natural product libraries for anti-cancer activity using native mass spectrometry. This exciting project is supervised
-
([email protected] ) 3) Precision oncology targeting of drug-resistant ovarian cancer ([email protected] ) 4) Using multi-omics to identify severe asthma patients that respond
-
makes people's health and strength worse overall. Colorectal cancer patients also lose significant amounts of mass and have a high levels of inflammation, both of which are linked to worse long-term